BSX

Boston Scientific
D

BSX

Arincen84/100B

Boston Scientific total debt 1991–2026

Boston Scientific's total debt was 11.95B USD on 30 September 2026, down 0.8% on a year before. At the end of fiscal year 2025 it was 11.85B USD.

Last updated 7 Nov 2026 · Next report 3 Feb 2027

Total debt

Growth

Fiscal yearPeriod endingTotal debtGrowthCash and short-term investmentsNet cashDebt to equity
Latest quarter30 Sept 202611.95B-0.77%609.00M-11.34B0.47
FY202531 Dec 202511.85B+6.28%2.05B-9.80B0.49
FY202431 Dec 202411.15B+17.44%414.00M-10.73B0.51
FY202331 Dec 20239.49B+2.26%865.00M-8.63B0.49
FY202231 Dec 20229.28B-1.79%928.00M-8.35B0.53
FY202131 Dec 20219.45B-0.92%1.93B-7.53B0.57
FY202031 Dec 20209.54B-7.18%1.73B-7.81B0.62
FY201931 Dec 201910.28B+46.19%217.00M-10.06B0.74
FY201831 Dec 20187.03B+26.03%146.00M-6.88B0.81
FY201731 Dec 20175.58B+1.71%188.00M-5.39B0.80
FY201631 Dec 20165.48B-3.40%196.00M-5.29B0.81
FY201531 Dec 20155.68B+33.20%319.00M-5.36B0.90
FY201431 Dec 20144.26B+0.52%587.00M-3.68B0.62
FY201331 Dec 20134.24B-0.38%217.00M-4.02B0.65
FY201231 Dec 20124.26B-0.12%207.00M-4.05B0.62
FY201131 Dec 20114.26B-21.64%267.00M-3.99B0.38
FY201031 Dec 20105.44B-8.11%213.00M-5.23B0.48
FY200931 Dec 20095.92B-12.26%864.00M-5.05B0.48
FY200831 Dec 20086.75B-17.63%1.64B-5.10B0.51
FY200731 Dec 20078.19B-8.01%1.45B-6.74B0.54
FY200631 Dec 20068.90B+340.69%1.67B-7.23B0.58
FY200531 Dec 20052.02B-14.66%848.00M-1.17B0.47
FY200431 Dec 20042.37B+37.22%1.64B-727.00M0.59
FY200331 Dec 20031.73B+84.49%671.00M-1.05B0.60
FY200231 Dec 2002935.00M-22.34%277.00M-658.00M0.38
FY200131 Dec 20011.20B+44.36%185.00M-1.02B0.60
FY200031 Dec 2000834.00M-34.74%60.00M-774.00M0.43
FY199931 Dec 19991.28B-46.56%78.00M-1.20B0.74
FY199831 Dec 19982.39B+384.56%70.30M-2.32B2.91
FY199731 Dec 1997493.50M+71.47%58.00M-435.50M0.50
FY199631 Dec 1996287.80M+305.35%58.50M-229.30M0.31
FY199531 Dec 199571.00M+64.73%115.00M44.00M0.09
FY199431 Dec 199443.10M+21.41%90.10M47.00M0.13
FY199331 Dec 199335.50M+36.02%60.80M25.30M0.14
FY199231 Dec 199226.10M+3.57%95.40M69.30M0.10
FY199131 Dec 199125.20M—5.90M-19.30M0.28

Figures in USD at the end of each period. Net cash is cash and short-term investments less total debt; book value per share is on the diluted share count. The latest column is the most recent quarter.

Total debt counts commercial paper, term debt and lease liabilities.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Free cash flow,Stock buybacks,Balance sheet

Common questions about Boston Scientific's debt

Source: Financial Modeling Prep